tiprankstipranks
Advertisement
Advertisement
Design Therapeutics management to meet with Oppenheimer
PremiumThe FlyDesign Therapeutics management to meet with Oppenheimer
18d ago
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
Premium
The Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
21d ago
Design Therapeutics management to meet with Oppenheimer
Premium
The Fly
Design Therapeutics management to meet with Oppenheimer
1M ago
Controversial Prasad leaving FDA, NYT reports
PremiumThe FlyControversial Prasad leaving FDA, NYT reports
2M ago
Design Therapeutics announces governance-driven board resignation
Premium
Company Announcements
Design Therapeutics announces governance-driven board resignation
3M ago
Design Therapeutics initiated with an Outperform at Oppenheimer
Premium
The Fly
Design Therapeutics initiated with an Outperform at Oppenheimer
4M ago
RBC upgrades Design Therapeutics to Outperform into ‘more eventful’ 2026
PremiumThe FlyRBC upgrades Design Therapeutics to Outperform into ‘more eventful’ 2026
6M ago
Design Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
Premium
The Fly
Design Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
6M ago
Design Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Design Therapeutics Reports Q3 2025 Financial Results
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100